MACKAY MARTIN
Insider CIK 1414815 · CRL Director · RLYB Executive Chairman, Director · SWTX Director · FVAM Director · KLRA Director · ALXN EVP & Global Head of R&D
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRL CHARLES RIVER LABORATORIES | A Award | 2026-05-08 | 2026-05-11 | 1,407 | $177.62 | $249.9K | 17,137 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2026-05-08 | 2026-05-11 | 1,438 | $177.62 | $255.4K | 15,730 | SEC↗ |
| KLRA Kailera Therapeutics, Inc. | A Award deriv | 2026-04-16 | 2026-04-20 | 38,300 | — | $0 | 38,300 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2026-02-18 | 2026-02-20 | 18,055 | $3.60 | $65.0K | 18,055 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 29,445 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 20,023 | — | $0 | 0 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2025-05-21 | 2025-05-23 | 2,076 | $134.98 | $280.2K | 2,076 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2025-05-21 | 2025-05-23 | 946 | $134.98 | $127.7K | 13,477 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2025-05-21 | 2025-05-23 | 815 | $134.98 | $110.0K | 14,292 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-05-14 | 2025-05-15 | 10,060 | — | $0 | 20,023 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-05-13 | 2025-05-15 | 28,500 | — | $0 | 28,500 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-01-02 | 2025-01-06 | 92,857 | $0.70 | $65.0K | 92,857 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-07-29 | 2024-07-30 | 29,445 | — | $0 | 29,445 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-07-29 | 2024-07-30 | 9,963 | — | $0 | 9,963 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2024-05-13 | 2024-05-15 | 1,311 | $228.41 | $299.4K | 1,311 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2024-05-13 | 2024-05-15 | 559 | $228.41 | $127.7K | 12,159 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2024-05-13 | 2024-05-15 | 372 | $228.41 | $85.0K | 12,531 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-02-15 | 2024-02-16 | 216,000 | — | $0 | 216,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2023-07-03 | 2023-07-05 | 95 | — | $0 | 11,600 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2023-05-31 | 2023-06-02 | 338 | — | $0 | 11,505 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2023-05-15 | 2023-05-17 | 1,669 | $192.36 | $321.0K | 1,669 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2023-05-15 | 2023-05-17 | 664 | — | $0 | 11,167 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-02-06 | 2023-02-06 | 214,000 | — | $0 | 214,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2022-05-11 | 2022-05-13 | 1,512 | $222.31 | $336.1K | 1,512 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2022-05-11 | 2022-05-13 | 549 | — | $0 | 10,211 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2022-05-11 | 2022-05-13 | 292 | — | $0 | 10,503 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-02-07 | 2022-02-09 | 62,000 | — | $0 | 62,000 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2022-01-11 | 2022-01-12 | 4,496 | $10.65 | $47.9K | 282,609 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2022-01-10 | 2022-01-12 | 5,504 | $10.10 | $55.6K | 278,113 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2022-01-03 | 2022-01-04 | 63 | — | $0 | 9,662 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2021-07-28 | 2022-01-12 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2022-01-12 | 107,891 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2022-01-12 | 150,000 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2022-01-12 | 2,564,999 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2022-01-12 | 2,255,001 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2022-01-12 | 100,000 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2022-01-12 | 272,609 | — | $0 | 272,609 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2022-01-12 | 436,517 | — | $0 | 436,517 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2021-05-07 | 2021-05-10 | 1,151 | — | $0 | 1,151 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2021-05-07 | 2021-05-10 | 219 | — | $0 | 9,599 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2021-05-07 | 2021-05-10 | 355 | — | $0 | 9,380 | SEC↗ |
| FVAM 5:01 Acquisition Corp. | J Other deriv | 2020-10-16 | 2020-10-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2020-05-11 | 2020-05-12 | 2,539 | — | $0 | 2,539 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2020-05-11 | 2020-05-12 | 741 | — | $0 | 8,568 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2020-05-11 | 2020-05-12 | 457 | — | $0 | 9,025 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2019-05-22 | 2019-05-23 | 599 | — | $0 | 7,827 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2019-05-22 | 2019-05-23 | 1,882 | — | $0 | 7,228 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2018-05-14 | 2018-05-16 | 560 | — | $0 | 5,346 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2018-05-14 | 2018-05-16 | 2,004 | — | $0 | 4,786 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2017-08-01 | 2017-08-03 | 607 | — | $0 | 2,782 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2017-08-01 | 2017-08-03 | 2,175 | — | $0 | 2,175 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-03-01 | 2017-03-01 | 370 | $132.50 | $49.0K | 50,688 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2017-02-28 | 2017-03-01 | 12,800 | — | $0 | 12,800 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-02-28 | 2017-03-01 | 12,800 | — | $0 | 51,058 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-28 | 2017-03-01 | 625 | $131.70 | $82.3K | 38,258 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-27 | 2017-03-01 | 860 | $131.20 | $112.8K | 38,883 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-09 | 2017-02-10 | 217 | $126.84 | $27.5K | 39,743 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-06 | 2017-02-08 | 2,710 | $125.69 | $340.6K | 39,978 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2017-02-06 | 2017-02-08 | 18 | $126.88 | $2.3K | 39,960 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-05-16 | 2016-05-18 | 18 | $140.43 | $2.5K | 42,688 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-05-16 | 2016-05-18 | 4,079 | $139.19 | $567.8K | 42,706 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 1,000 | $138.91 | $138.9K | 46,785 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-02-26 | 2016-03-01 | 31,000 | $140.16 | $4.34M | 31,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-26 | 2016-03-01 | 7,000 | — | $0 | 47,785 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 1,908 | $138.02 | $263.3K | 40,785 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 58 | $140.32 | $8.1K | 42,693 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 100 | $142.11 | $14.2K | 44,194 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 100 | $143.53 | $14.4K | 44,294 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 362 | $144.40 | $52.3K | 44,394 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 1,043 | $140.47 | $146.5K | 42,751 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $141.19 | $56.5K | 43,794 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 100 | $145.54 | $14.6K | 44,756 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-04 | 2016-02-08 | 11,763 | — | $0 | 44,656 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2015-08-03 | 2015-08-05 | 15,375 | $176.80 | $2.72M | 33,825 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2015-08-03 | 2015-08-05 | 28,125 | $104.86 | $2.95M | 37,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-03 | 2015-08-05 | 8,882 | $195.19 | $1.73M | 32,893 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-03 | 2015-08-05 | 17,518 | $196.48 | $3.44M | 41,775 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-03 | 2015-08-05 | 17,100 | $197.24 | $3.37M | 59,293 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2015-08-03 | 2015-08-05 | 15,375 | $176.80 | $2.72M | 76,393 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2015-08-03 | 2015-08-05 | 28,125 | $104.86 | $2.95M | 61,018 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-05-14 | 2015-05-22 | 4,056 | $160.33 | $650.3K | 32,893 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-03-02 | 2015-03-03 | 370 | $180.34 | $66.7K | 36,949 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 5,100 | — | $0 | 37,319 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,907 | $176.91 | $337.4K | 32,219 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,990 | $171.15 | $340.6K | 34,126 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-05 | 2015-02-09 | 11,690 | — | $0 | 36,116 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-03 | 2014-11-04 | 9,375 | $104.86 | $983.1K | 65,625 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 9,375 | $191.52 | $1.80M | 24,426 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-03 | 2014-11-04 | 9,375 | $104.86 | $983.1K | 33,801 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-06-12 | 2014-06-13 | 25,000 | $104.86 | $2.62M | 75,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-06-12 | 2014-06-13 | 5,058 | $165.88 | $839.0K | 44,368 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-06-12 | 2014-06-13 | 15,949 | $166.35 | $2.65M | 28,419 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-06-12 | 2014-06-13 | 3,993 | $167.40 | $668.4K | 24,426 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-06-12 | 2014-06-13 | 25,000 | $104.86 | $2.62M | 49,426 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-05-14 | 2014-05-15 | 3,574 | $160.85 | $574.9K | 24,426 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 49,200 | — | $0 | 49,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 3,000 | — | $0 | 28,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-05-13 | 2013-05-15 | 100,000 | $104.86 | $10.49M | 100,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-05-13 | 2013-05-15 | 25,000 | — | $0 | 25,000 | SEC↗ |